Treatment adherence improvement in COPD patients after initiation of Extrafine Beclometasone Dipropionate, Formoterol, and Glycopyrronium in DPI formulation: results from the RESPONSE study. (ERS 2026) - May 30, 2026 - Abstract #PA2578; Pres time: Sep 7, 2026; 08:00 AM - 09:30 AM; Location: PS-14; Board Number: 17; " RESPONSE is an observational, prospective study involving four European countries (Czechia, Bulgaria, Slovenia, Hungary), investigating effectiveness of Trimbow 88/5/9 inhalation powder treatment over 6 months, switching from LABA-LAMA or ICS-LABA in moderate and severe COPD patients... In moderate and severe COPD patients, switching from LABA/LAMA or ICS/LABA to SITT with BDP/FF/G in DPI formulation is associated with a significant improvement of adherence to inhalers. These results confirm the potential role of SITT in improving the treatment adherence in COPD patients."
Adherence • Clinical • Chronic Obstructive Pulmonary Disease • Immunology • Respiratory Diseases
|
|
R. Petkov; E. Mekov; T. Mihalova; M. Harlander; S. Genzor; N. Rodopska; I. Horváth
|